Role of platelets in neonatal necrotizing enterocolitis

Area of Science:

• Neonatal Medicine
• Hematology
• Gastroenterology

Background:

• Necrotizing enterocolitis (NEC) is a severe intestinal disease in premature infants.
• Thrombocytopenia (low platelet count) affects 50-95% of NEC infants, often requiring platelet transfusions.
• The mechanisms and implications of NEC-related thrombocytopenia are not fully understood.

Purpose of the Study:

• To review current evidence on the clinical features and mechanisms of platelet depletion in NEC.
• To explore the potential protective role of moderate thrombocytopenia in NEC.
• To present a novel neonatal murine model of NEC-related thrombocytopenia.

Main Methods:

• Comprehensive literature search of PubMed, EMBASE, and Scopus databases.
• Analysis of anecdotal clinical experience and pediatric academic society abstracts.
• Development and utilization of a neonatal murine model using trinitrobenzene sulfonate.

Main Results:

• Infants with NEC frequently develop thrombocytopenia within 72 hours of diagnosis.
• Early findings suggest moderate thrombocytopenia might be protective in human NEC.
• The murine model replicates NEC-like ileocolitis and demonstrates protective thrombocytopenia.

Conclusions:

• NEC-associated thrombocytopenia is common and requires further mechanistic study.
• Moderate thrombocytopenia may confer a protective effect in NEC, warranting further investigation.
• The developed murine model provides a valuable tool for studying NEC pathogenesis and platelet dynamics.